FDA on Sinopharm EUA: “Patapos na rin po ang evaluation”
The Food and Drug Administration (FDA) on Wednesday said that it would finish the evaluation of documents submitted by the Department of Health (DOH) on the application for emergency use authorization (EUA) of Sinopharm vaccine.
On Wednesday evening, FDA Director-General Eric Domingo revealed during a televised Cabinet meeting that the Department of Health (DOH) had applied for Sinopharm’s EUA in the Philippines.
“Iyon pong Sinopharm, nag-apply na rin po ang DOH noong May 20 and patapos na rin po ang evaluation ng mga experts sa data na nakuha natin and it seems to be very favorable,” Domingo said.
Domingo also noted that only a few more documents were still to be submitted by the Department of Health and he’s expecting that a decision will be released towards the end of this week or early next week.
READ ALSO: FDA Hopes Evaluations For Sinopharm COVID-19 Vaccine To Get EUA Will Be Completed Soon
It was last May 8 when Health Secretary Francisco Duque III said that he already instructed his department’s public health services office to file the emergency use authorization for Sinopharm COVID-19 vaccine with the Food and Drug Administration so that the Philippines didn’t have to return a batch of donated vaccine doses by China.
The Food and Drug Administration said on May 11 that it may take at least 2 weeks to know if the said vaccine will be granted an emergency use authorizationin the Philippines.
Once authorized in the country, the said vaccine will be the 8th vaccine manufacturer in the country to get regulatory approval from the FDA following Pfizer-BioNTech, AstraZeneca-Oxford, Sinovac Biotech, Bharat Biotech, Janssen Pharmaceuticals, Gamaleya, and Moderna.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.
